Shadia A. Sharf

  • Citations Per Year
Learn More
Quality of life (QoL) is important as an outcome measurement, especially for long-term diseases. Patients with end stage renal disease have several co-morbidities which may have significant adverse effects. Moreover, the patients are prone to non-compliance and all these significantly affect their QoL. This study was conducted to assess the QoL exhibited by(More)
A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each evaluation. Liver function tests (LFT) were performed to(More)
A total of 895 CEA estimations were carried out on serum samples from 283 patients with different primary tumor sites. All assays were performed during the period of follow up or treatment of the patients. Concomitantly with CEA estimation, activity of disease was recorded, based on objective laboratory and clinical parameters. The results obtained proved a(More)
  • 1